Company
ZEVRA THERAPEUTICS, INC. (ZVRA)
Standardized SEC financial data for ZEVRA THERAPEUTICS, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001434647 · NASDAQ · Pharmaceutical Preparations.
Gross margin
84.5%
Operating margin
-59.1%
Net margin
72.9%
Revenue growth (YoY)
350.9%
Return on equity
50.2%
ROIC
-39.2%
Free cash flow
-$2.4M
Debt / equity
0.40×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $13.3M | $28.6M | $10.2M | $27.5M | $23.6M | $106.5M |
| Cost of revenue |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $112.3M | $65.5M | — | $67.7M | $33.8M | $62.4M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.9M | $10.4M | -$18.7M | -$33.5M | -$69.7M | -$1.6M |
| Capital expenditures |
Get ZVRA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ZVRA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ZVRA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"